Literature DB >> 15124102

Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome.

Ilse Wieland1, Sibylle Jakubiczka, Petra Muschke, Monika Cohen, Hannelore Thiele, Klaus L Gerlach, Ralf H Adams, Peter Wieacker.   

Abstract

Craniofrontonasal syndrome (CFNS) is an X-linked craniofacial disorder with an unusual manifestation pattern, in which affected females show multiple skeletal malformations, whereas the genetic defect causes no or only mild abnormalities in male carriers. Recently, we have mapped a gene for CFNS in the pericentromeric region of the X chromosome that contains the EFNB1 gene, which encodes the ephrin-B1 ligand for Eph receptors. Since Efnb1 mutant mice display a spectrum of malformations and an unusual inheritance reminiscent of CFNS, we analyzed the EFNB1 gene in three families with CFNS. In one family, a deletion of exons 2-5 was identified in an obligate carrier male, his mildly affected brother, and in the affected females. In the two other families, missense mutations in EFNB1 were detected that lead to amino acid exchanges P54L and T111I. Both mutations are located in multimerization and receptor-interaction motifs found within the ephrin-B1 extracellular domain. In all cases, mutations were found consistently in obligate male carriers, clinically affected males, and affected heterozygous females. We conclude that mutations in EFNB1 cause CFNS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15124102      PMCID: PMC1182084          DOI: 10.1086/421532

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

Review 1.  Multiple roles of EPH receptors and ephrins in neural development.

Authors:  D G Wilkinson
Journal:  Nat Rev Neurosci       Date:  2001-03       Impact factor: 34.870

2.  Crystal structure of an Eph receptor-ephrin complex.

Authors:  J P Himanen; K R Rajashankar; M Lackmann; C A Cowan; M Henkemeyer; D B Nikolov
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

Review 3.  Mechanisms and functions of Eph and ephrin signalling.

Authors:  Klas Kullander; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2002-07       Impact factor: 94.444

Review 4.  'Eph'ective signaling: forward, reverse and crosstalk.

Authors:  Keith K Murai; Elena B Pasquale
Journal:  J Cell Sci       Date:  2003-07-15       Impact factor: 5.285

5.  Control of skeletal patterning by ephrinB1-EphB interactions.

Authors:  Amelia Compagni; Malcolm Logan; Rüdiger Klein; Ralf H Adams
Journal:  Dev Cell       Date:  2003-08       Impact factor: 12.270

6.  A first-generation X-inactivation profile of the human X chromosome.

Authors:  L Carrel; A A Cottle; K C Goglin; H F Willard
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

7.  Metabolic interference and the + - heterozygote. a hypothetical form of simple inheritance which is neither dominant nor recessive.

Authors:  W G Johnson
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

8.  An ephrin mimetic peptide that selectively targets the EphA2 receptor.

Authors:  Mitchell Koolpe; Monique Dail; Elena B Pasquale
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

9.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.

Authors:  R C Allen; H Y Zoghbi; A B Moseley; H M Rosenblatt; J W Belmont
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

10.  Mapping of a further locus for X-linked craniofrontonasal syndrome.

Authors:  I Wieland; S Jakubiczka; P Muschke; A Wolf; L Gerlach; M Krawczak; P Wieacker
Journal:  Cytogenet Genome Res       Date:  2002       Impact factor: 1.636

View more
  69 in total

1.  Disruption of ALX1 causes extreme microphthalmia and severe facial clefting: expanding the spectrum of autosomal-recessive ALX-related frontonasal dysplasia.

Authors:  Elif Uz; Yasemin Alanay; Dilek Aktas; Ibrahim Vargel; Safak Gucer; Gokhan Tuncbilek; Ferdinand von Eggeling; Engin Yilmaz; Ozgur Deren; Nicole Posorski; Hilal Ozdag; Thomas Liehr; Sevim Balci; Mehmet Alikasifoglu; Bernd Wollnik; Nurten A Akarsu
Journal:  Am J Hum Genet       Date:  2010-05-06       Impact factor: 11.025

Review 2.  The role of Eph/ephrin molecules in stromal–hematopoietic interactions.

Authors:  Thao M Nguyen; Agnieszka Arthur; Stan Gronthos
Journal:  Int J Hematol       Date:  2016-02       Impact factor: 2.490

Review 3.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

Review 4.  Mechanisms of ephrin-Eph signalling in development, physiology and disease.

Authors:  Artur Kania; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

Review 5.  Eph/ephrin signaling: networks.

Authors:  Dina Arvanitis; Alice Davy
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

Review 6.  Signaling and transcriptional regulation in osteoblast commitment and differentiation.

Authors:  Wei Huang; Shuying Yang; Jianzhong Shao; Yi-Ping Li
Journal:  Front Biosci       Date:  2007-05-01

7.  Phenotypes of craniofrontonasal syndrome in patients with a pathogenic mutation in EFNB1.

Authors:  M E P van den Elzen; S R F Twigg; J A C Goos; A J M Hoogeboom; A M W van den Ouweland; A O M Wilkie; I M J Mathijssen
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

8.  A Family with Craniofrontonasal Syndrome and a Mutation (p.G151S) in the EFNB1 Gene: Expanding the Phenotype.

Authors:  Jaime Toral-López; Luz M González-Huerta; Olga Messina Baas; Sergio A Cuevas-Covarrubias
Journal:  Mol Syndromol       Date:  2016-03-19

9.  Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism.

Authors:  Jeffrey O Bush; Philippe Soriano
Journal:  Genes Dev       Date:  2009-06-10       Impact factor: 11.361

Review 10.  Craniosynostosis: molecular pathways and future pharmacologic therapy.

Authors:  Kshemendra Senarath-Yapa; Michael T Chung; Adrian McArdle; Victor W Wong; Natalina Quarto; Michael T Longaker; Derrick C Wan
Journal:  Organogenesis       Date:  2012-10-01       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.